{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:31:32Z","timestamp":1786699892552,"version":"build-2736575974"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004515","name":"Universiti Kebangsaan Malaysia","doi-asserted-by":"publisher","award":["GGP-2020-043"],"award-info":[{"award-number":["GGP-2020-043"]}],"id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12565-5","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:46:41Z","timestamp":1786697201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unravelling the phytochemical complexity of neuroprotective plants: a metabolomics approach to Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"53","author":[{"given":"Shubatra Nahenthara","family":"Raj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya Erna","family":"Natnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wong Pei","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mediani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tewin","family":"Tencomnao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syarul Nataqain","family":"Baharum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"12565_CR1","doi-asserted-by":"publisher","first-page":"102481","DOI":"10.1016\/j.arr.2024.102481","volume":"101","author":"PT Kamatham","year":"2024","unstructured":"Kamatham PT, Shukla RK, Khatri DK, Vora LK (2024) Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: Breaking the memory barrier. Ageing Res Rev 101:102481\u2013102481. https:\/\/doi.org\/10.1016\/j.arr.2024.102481","journal-title":"Ageing Res Rev"},{"issue":"2","key":"12565_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","volume":"16","author":"Q Zheng","year":"2024","unstructured":"Zheng Q, Wang X (2024) Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy. Protein Cell 16(2):83\u2013120. https:\/\/doi.org\/10.1093\/procel\/pwae026","journal-title":"Protein Cell"},{"issue":"6","key":"12565_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41580-019-0108-4","volume":"20","author":"MM Rinschen","year":"2019","unstructured":"Rinschen MM, Ivani\u0161evi\u0107 J, Giera M, Siuzdak G (2019) Identification of bioactive metabolites using activity metabolomics. OSTI OAI (U.S. Department of Energy. Office Sci Tech Information) 20(6):353\u2013367. https:\/\/doi.org\/10.1038\/s41580-019-0108-4","journal-title":"Office Sci Tech Information)"},{"key":"12565_CR4","doi-asserted-by":"publisher","first-page":"115184","DOI":"10.1016\/j.biopha.2023.115184","volume":"165","author":"B Kutryb-Zaj\u0105c","year":"2023","unstructured":"Kutryb-Zaj\u0105c B, Kawecka A, Nasadiuk K, Braczko A, Stawarska K, Caiazzo E, Kosza\u0142ka P, Cicala C (2023) Drugs targeting adenosine signaling pathways: A current view. Biomed Pharmacother 165:115184\u2013115184. https:\/\/doi.org\/10.1016\/j.biopha.2023.115184","journal-title":"Biomed Pharmacother"},{"key":"12565_CR5","doi-asserted-by":"publisher","first-page":"9829176","DOI":"10.1155\/2020\/9829176","volume":"23","author":"SD Meo","year":"2020","unstructured":"Meo SD, Venditti P (2020) Evolution of the knowledge of free radicals and other oxidants. Oxid Med Cell Longev 23:9829176. https:\/\/doi.org\/10.1155\/2020\/9829176","journal-title":"Oxid Med Cell Longev"},{"key":"12565_CR6","doi-asserted-by":"publisher","first-page":"215052","DOI":"10.1016\/j.ccr.2023.215052","volume":"481","author":"GR Navale","year":"2023","unstructured":"Navale GR, Singh S, Ghosh K (2023) NO donors as the wonder molecules with therapeutic potential: Recent trends and future perspectives. Coord Chem Rev 481:215052. https:\/\/doi.org\/10.1016\/j.ccr.2023.215052","journal-title":"Coord Chem Rev"},{"issue":"16","key":"12565_CR7","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1016\/j.cell.2022.06.010","volume":"185","author":"JO Lundberg","year":"2022","unstructured":"Lundberg JO, Weitzberg E (2022) Nitric oxide signaling in health and disease. Cell 185(16):2853\u20132878. https:\/\/doi.org\/10.1016\/j.cell.2022.06.010","journal-title":"Cell"},{"key":"12565_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s40279-023-01870-9","volume":"53","author":"DG Candow","year":"2023","unstructured":"Candow DG, Forbes SC, Ostoji\u0107 SM, Prokopidis K, Stock MS, Harmon KK, Faulkner P (2023) Heads Up for creatine supplementation and its potential applications for brain health and function. Sports Med 53:49\u201365. https:\/\/doi.org\/10.1007\/s40279-023-01870-9","journal-title":"Sports Med"},{"issue":"4","key":"12565_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.64719\/pb.4169","volume":"37","author":"CB Nemeroff","year":"2025","unstructured":"Nemeroff CB (2025) The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull 37(4):133\u2013146. https:\/\/doi.org\/10.64719\/pb.4169","journal-title":"Psychopharmacol Bull"},{"issue":"1","key":"12565_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","volume":"8","author":"S Qiu","year":"2023","unstructured":"Qiu S, Cai Y, Yao H, Lin C, Xie Y, Tang S, Zhang A (2023) Small molecule metabolites: Discovery of biomarkers and therapeutic targets. Signal Transduct Target Ther 8(1):132\u2013132. https:\/\/doi.org\/10.1038\/s41392-023-01399-3","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"12565_CR11","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","volume":"99","author":"DS Wishart","year":"2019","unstructured":"Wishart DS (2019) Metabolomics for investigating physiological and pathophysiological processes. Physiol Rev 99(4):1819\u20131875. https:\/\/doi.org\/10.1152\/physrev.00035.2018","journal-title":"Physiol Rev"},{"issue":"6","key":"12565_CR12","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/nu12061616","volume":"12","author":"M Mehmel","year":"2020","unstructured":"Mehmel M, Jovanovi\u0107 N, Spitz U (2020) Nicotinamide riboside\u2014the current state of research and therapeutic uses. Nutrients 12(6):1616. https:\/\/doi.org\/10.3390\/nu12061616","journal-title":"Nutrients"},{"key":"12565_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jmsacl.2023.02.003","volume":"28","author":"S Rischke","year":"2023","unstructured":"Rischke S, Hahnefeld L, Burla B, Behrens F, Gurke R, Garrett TJ (2023) Small molecule biomarker discovery: Proposed workflow for LC-MS-based clinical research projects. J Mass Spectrom Adv Clin Lab 28:47\u201355. https:\/\/doi.org\/10.1016\/j.jmsacl.2023.02.003","journal-title":"J Mass Spectrom Adv Clin Lab"},{"key":"12565_CR14","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3390\/molecules27041223","volume":"27","author":"CS Seo","year":"2022","unstructured":"Seo CS, Shin HK (2022) Simultaneous analysis for quality control of traditional herbal medicine, Gungha-Tang, using liquid chromatography\u2013tandem mass spectrometry. Molecules 27:1223. https:\/\/doi.org\/10.3390\/molecules27041223","journal-title":"Molecules"},{"key":"12565_CR15","doi-asserted-by":"publisher","first-page":"464505","DOI":"10.1016\/j.chroma.2023.464505","volume":"1713","author":"H Zhang","year":"2024","unstructured":"Zhang H, Jiang X, Zhang D, Yang Y, Xie Q, Wu C (2024) An integrated approach for studying the metabolic profiling of herbal medicine in mice using high-resolution mass spectrometry and metabolomics data processing tools. J Chromatogr A 1713:464505. https:\/\/doi.org\/10.1016\/j.chroma.2023.464505","journal-title":"J Chromatogr A"},{"issue":"1","key":"12565_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/plants12010059","volume":"12","author":"R Ahmad","year":"2023","unstructured":"Ahmad R, Rosandy AR, Sahidin I, Ab Ghani NS, Noor NM, Baharum SN (2023) Bioassay analysis and molecular docking study revealed the potential medicinal activities of active compounds Polygonumins B, C and D from Polygonum minus (Persicaria minor). Plants 12(1):59. https:\/\/doi.org\/10.3390\/plants12010059","journal-title":"Plants"},{"issue":"11","key":"12565_CR17","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.22038\/ijbms.2024.77760.16826","volume":"27","author":"A Mishra","year":"2024","unstructured":"Mishra A, Krishnamurthy S (2024) Recent advancements in the role of phytochemicals and medicinal plants in prophylaxis and management of Alzheimer\u2019s disease. Iran J Basic Med Sci 27(11):1357\u20131369. https:\/\/doi.org\/10.22038\/ijbms.2024.77760.16826","journal-title":"Iran J Basic Med Sci"},{"key":"12565_CR18","unstructured":"World Alzheimer report 2023. Alzheimer\u2019s Disease International (2023) Journey through the diagnosis of dementia. https:\/\/www.alzint.org\/resource\/world-alzheimer-report-2023"},{"issue":"14","key":"12565_CR19","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3390\/plants11141792","volume":"11","author":"HA Abbas","year":"2022","unstructured":"Abbas HA, Salama AM, El-Toumy SAA, Salama AA, Tadros SH, El Gedaily RA (2022) Novel neuroprotective potential of Bunchosia armeniaca (Cav.) DC against lipopolysaccharide induced alzheimer\u2019s disease in mice. Plants 11(14):1792. https:\/\/doi.org\/10.3390\/plants11141792","journal-title":"Plants"},{"issue":"1","key":"12565_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/neup.12626","volume":"40","author":"R Sengoku","year":"2020","unstructured":"Sengoku R (2020) Aging and Alzheimer\u2019s disease pathology. Neuropathology 40(1):22\u201329. https:\/\/doi.org\/10.1111\/neup.12626","journal-title":"Neuropathology"},{"key":"12565_CR21","doi-asserted-by":"publisher","first-page":"1248727","DOI":"10.3389\/fnins.2023.1248727","volume":"17","author":"C Sanfeliu","year":"2024","unstructured":"Sanfeliu C, Bartra C, Su\u00f1ol C, Rodr\u00edguez-Farr\u00e9 E (2024) New insights in animal models of neurotoxicity-induced neurodegeneration. Front Neurosci 17:1248727. https:\/\/doi.org\/10.3389\/fnins.2023.1248727","journal-title":"Front Neurosci"},{"issue":"16","key":"12565_CR22","doi-asserted-by":"publisher","first-page":"11057","DOI":"10.1039\/d3ra08333k","volume":"14","author":"EA Abdallah","year":"2024","unstructured":"Abdallah EA (2024) Review on anti-alzheimer drug development: Approaches, challenges and perspectives. RSC Adv 14(16):11057\u201311088. https:\/\/doi.org\/10.1039\/d3ra08333k","journal-title":"RSC Adv"},{"issue":"6","key":"12565_CR23","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/molecules27061816","volume":"27","author":"ZR Chen","year":"2022","unstructured":"Chen ZR, Huang JB, Yang SL, Hong F (2022) Role of cholinergic signaling in Alzheimer\u2019s disease. molecules (Basel. Switzerland) 27(6):1816. https:\/\/doi.org\/10.3390\/molecules27061816","journal-title":"Switzerland)"},{"key":"12565_CR24","doi-asserted-by":"publisher","first-page":"1637029","DOI":"10.3389\/fnagi.2025.1637029","volume":"17","author":"H Fu","year":"2025","unstructured":"Fu H, Huang H, Liao S, Dai Z (2025) Global burden of Alzheimer\u2019s disease and other dementias (1990\u20132021): Inequality, frontier, and decomposition analysis. Front Aging Neurosci 17:1637029\u20131637029. https:\/\/doi.org\/10.3389\/fnagi.2025.1637029","journal-title":"Front Aging Neurosci"},{"key":"12565_CR25","doi-asserted-by":"publisher","first-page":"698337","DOI":"10.3389\/fmolb.2021.698337","volume":"8","author":"MPM Letertre","year":"2021","unstructured":"Letertre MPM, Giraudeau P, de Tullio P (2021) Nuclear magnetic resonance spectroscopy in clinical metabolomics and personalized medicine: Current challenges and perspectives. Front Mol Biosci 8:698337. https:\/\/doi.org\/10.3389\/fmolb.2021.698337","journal-title":"Front Mol Biosci"},{"issue":"40","key":"12565_CR26","doi-asserted-by":"publisher","first-page":"22335","DOI":"10.1039\/c8ra01574k","volume":"8","author":"J Ren","year":"2018","unstructured":"Ren J, Zhang A, Kong L, Wang X (2018) Advances in mass spectrometry-based metabolomics for investigation of metabolites. RSC Adv 8(40):22335\u201322350. https:\/\/doi.org\/10.1039\/c8ra01574k","journal-title":"RSC Adv"},{"issue":"9","key":"12565_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11306-021-01828-w","volume":"17","author":"P Reveglia","year":"2021","unstructured":"Reveglia P, Paolillo C, Ferretti G, Carlo AD, Angiolillo A, Nasso R, Caputo M, Matrone C, Costanzo AD, Corso G (2021) Challenges in LC\u2013MS-based metabolomics for Alzheimer\u2019s disease early detection: Targeted approaches versus untargeted approaches. Metabolomics 17(9):78\u201378. https:\/\/doi.org\/10.1007\/s11306-021-01828-w","journal-title":"Metabolomics"},{"issue":"4","key":"12565_CR28","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41596-022-00801-8","volume":"18","author":"S Sarmad","year":"2023","unstructured":"Sarmad S, Viant MR, Dunn WB, Goodacre R, Wilson ID, Chappell K, Griffin JL, O\u2019Donnell VB, Naicker B, Lewis MR, Suzuki T (2023) A proposed framework to evaluate the quality and reliability of targeted metabolomics assays from the UK Consortium on Metabolic Phenotyping (MAP\/UK). ORCA Online Res @Cardiff (Cardiff University) 18(4):1017\u20131027. https:\/\/doi.org\/10.1038\/s41596-022-00801-8","journal-title":"ORCA Online Res @Cardiff (Cardiff University)"},{"key":"12565_CR29","doi-asserted-by":"publisher","first-page":"100273","DOI":"10.1016\/j.forc.2020.100273","volume":"20","author":"RF Kranenburg","year":"2020","unstructured":"Kranenburg RF, Verduin J, Stuyver LI, de Ridder R, van Beek A, Colmsee E, van Asten AC (2020) Benefits of derivatization in GC\u2013MS-based identification of new psychoactive substances. Forensic Chem 20:100273. https:\/\/doi.org\/10.1016\/j.forc.2020.100273","journal-title":"Forensic Chem"},{"key":"12565_CR30","doi-asserted-by":"publisher","first-page":"113509","DOI":"10.1016\/j.jpba.2020.113509","volume":"190","author":"\u00d6C Zeki","year":"2020","unstructured":"Zeki \u00d6C, Eylem CC, Re\u00e7ber T, K\u0131r S, Nemutlu E (2020) Integration of GC\u2013MS and LC\u2013MS for untargeted metabolomics profiling. J Pharm Biomed Anal 190:113509. https:\/\/doi.org\/10.1016\/j.jpba.2020.113509","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"12565_CR31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/metabo12020194","volume":"12","author":"V Gonz\u00e1lez-Covarrubias","year":"2022","unstructured":"Gonz\u00e1lez-Covarrubias V, Mart\u00ednez-Mart\u00ednez E, del Bosque\u2010Plata L (2022) The potential of metabolomics in biomedical applications. Metabolites 12(2):194\u2013194. https:\/\/doi.org\/10.3390\/metabo12020194","journal-title":"Metabolites"},{"issue":"1","key":"12565_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41392-023-01380-0","volume":"8","author":"F Danzi","year":"2023","unstructured":"Danzi F, Pacchiana R, Mafficini A, Scupoli MT, Scarpa A, Donadelli M, Fiore A (2023) To metabolomics and beyond: A technological portfolio to investigate cancer metabolism. Signal Transduct Target Ther 8(1):137\u2013137. https:\/\/doi.org\/10.1038\/s41392-023-01380-0","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"12565_CR33","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1038\/s41467-022-34537-6","volume":"13","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Luo M, Zhang H, Yin Y, Cai Y, Zhu Z (2022) Metabolite annotation from knowns to unknowns through knowledge-guided multi-layer metabolic networking. Nat Commun 13(1):6656\u20136656. https:\/\/doi.org\/10.1038\/s41467-022-34537-6","journal-title":"Nat Commun"},{"key":"12565_CR34","doi-asserted-by":"publisher","first-page":"115324","DOI":"10.1016\/j.trac.2018.11.022","volume":"120","author":"WJ Nash","year":"2018","unstructured":"Nash WJ, Dunn WB (2018) From mass to metabolite in human untargeted metabolomics: Recent advances in annotation of metabolites applying liquid chromatography-mass spectrometry data. TrAC Trends Anal Chem 120:115324\u2013115324. https:\/\/doi.org\/10.1016\/j.trac.2018.11.022","journal-title":"TrAC Trends Anal Chem"},{"issue":"1","key":"12565_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/acs.analchem.4c04060","volume":"97","author":"TO Metz","year":"2025","unstructured":"Metz TO, Chang CH, Gautam V, Anjum A, Tian S, Wang F, Colby SM, Nunez JR, Blumer MR, Edison AS, Fiehn O, Jones DP, Li S, Morgan ET, Patti GJ, Ross DH, Shapiro MR, Williams AJ, Wishart DS (2025) Introducing identification probability for automated and transferable assessment of metabolite identification confidence in metabolomics and related studies. Anal Chem 97(1):1\u201311. https:\/\/doi.org\/10.1021\/acs.analchem.4c04060","journal-title":"Anal Chem"},{"issue":"12","key":"12565_CR36","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s13361-016-1469-y","volume":"27","author":"AC Schrimpe-Rutledge","year":"2016","unstructured":"Schrimpe-Rutledge AC, Codreanu SG, Sherrod SD, McLean JA (2016) Untargeted metabolomics strategies\u2014challenges and emerging directions. J Am Soc Mass Spectrom 27(12):1897\u20131905. https:\/\/doi.org\/10.1007\/s13361-016-1469-y","journal-title":"J Am Soc Mass Spectrom"},{"issue":"1","key":"12565_CR37","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12859-023-05383-0","volume":"24","author":"N Anwardeen","year":"2023","unstructured":"Anwardeen N, Diboun I, Mokrab Y, Al-Thani A, Elrayess MA (2023) Statistical methods and resources for biomarker discovery using metabolomics. BMC Bioinform 24(1):250\u2013250. https:\/\/doi.org\/10.1186\/s12859-023-05383-0","journal-title":"BMC Bioinform"},{"issue":"1","key":"12565_CR38","doi-asserted-by":"publisher","first-page":"6797","DOI":"10.1038\/s41598-024-56837-1","volume":"14","author":"T Oka","year":"2024","unstructured":"Oka T, Matsuzawa Y, Tsuneyoshi M, Nakamura Y, Aoshima K, Tsugawa H, Weiner MW, Aisen P, Petersen R, Jack CR, Jagust WJ, Trojanowki JQ, Toga AW, Beckett L, Green RC, Saykin AJ, Morris JC, Shaw LM, Liu E, Raj BA (2024) Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer\u2019s disease neuroimaging initiative cohort. Sci Rep 14(1):6797\u20136797. https:\/\/doi.org\/10.1038\/s41598-024-56837-1","journal-title":"Sci Rep"},{"issue":"1","key":"12565_CR39","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41467-020-14959-w","volume":"11","author":"M Arnold","year":"2020","unstructured":"Arnold M, Nho K, Kueider-Paisley A, Massaro T, Huynh K, Brauner B, MahmoudianDehkordi S, Louie G, Moseley MA, Thompson PM, John\u2010Williams LSt, Tenenbaum JD, Blach C, Chang R, Brinton RD, Baillie R, Han X, Trojanowski JQ, Shaw LM, Kastenm\u00fcller G (2020) Sex and APOE \u03b54 genotype modify the Alzheimer\u2019s disease serum metabolome. Nat Commun 11(1):1148\u20131148. https:\/\/doi.org\/10.1038\/s41467-020-14959-w","journal-title":"Nat Commun"},{"key":"12565_CR40","doi-asserted-by":"publisher","first-page":"904857","DOI":"10.3389\/fphar.2022.904857","volume":"13","author":"Z Dai","year":"2022","unstructured":"Dai Z, Tian H, Su S, Liu J, Ma Y, Zhuo Y, Fang S, Wang Q, Mo Z, Pan H, Fang J (2022) Comparative metabolomics analysis reveals key metabolic mechanisms and protein biomarkers in Alzheimer\u2019s disease. Front Pharmacol 13:904857\u2013904857. https:\/\/doi.org\/10.3389\/fphar.2022.904857","journal-title":"Front Pharmacol"},{"key":"12565_CR41","doi-asserted-by":"publisher","first-page":"1189659","DOI":"10.3389\/fnagi.2023.1189659","volume":"15","author":"J Yang","year":"2023","unstructured":"Yang J, Wu S, Yang J, Zhang Q, Dong X (2023) Amyloid beta-correlated plasma metabolite dysregulation in Alzheimer\u2019s disease: an untargeted metabolism exploration using high-resolution mass spectrometry toward future clinical diagnosis. Front Aging Neurosci 15:1189659\u20131189659. https:\/\/doi.org\/10.3389\/fnagi.2023.1189659","journal-title":"Front Aging Neurosci"},{"key":"12565_CR42","doi-asserted-by":"publisher","first-page":"704582","DOI":"10.3389\/fneur.2021.704582","volume":"12","author":"L Zhang","year":"2021","unstructured":"Zhang L, Li L, Meng F, Yu J, He F, Lin Y, Su Y, Hu M, Liu X, Liu Y, Luo B, Peng G (2021) Serum metabolites differentiate amnestic mild cognitive impairment from healthy controls and predict early Alzheimer\u2019s disease via untargeted lipidomics analysis. Front Neurol 12:704582\u2013704582. https:\/\/doi.org\/10.3389\/fneur.2021.704582","journal-title":"Front Neurol"},{"issue":"1","key":"12565_CR43","doi-asserted-by":"publisher","first-page":"9291","DOI":"10.1038\/s41598-018-27031-x","volume":"8","author":"L Hao","year":"2018","unstructured":"Hao L, Wang J, Page D, Asthana S, Zetterberg H, Carlsson CM, Okonkwo OC, Li L (2018) Comparative evaluation of MS-based metabolomics software and its application to preclinical Alzheimer\u2019s disease. Sci Rep 8(1):9291\u20139291. https:\/\/doi.org\/10.1038\/s41598-018-27031-x","journal-title":"Sci Rep"},{"key":"12565_CR44","doi-asserted-by":"publisher","first-page":"602887","DOI":"10.3389\/fcell.2021.602887","volume":"9","author":"K Xie","year":"2021","unstructured":"Xie K, Qin Q, Long Z, Yang Y, Peng C, Xi C, Li L, Wu Z, Daria V, Zhao Y, Wang F, Wang M (2021) High-throughput metabolomics for discovering potential biomarkers and identifying metabolic mechanisms in aging and Alzheimer\u2019s disease. Front Cell Dev Biol 9:602887\u2013602887. https:\/\/doi.org\/10.3389\/fcell.2021.602887","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"12565_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13024-018-0304-2","volume":"14","author":"Y Shao","year":"2019","unstructured":"Shao Y, Le W (2019a) Recent advances and perspectives of metabolomics-based investigations in Parkinson\u2019s disease. Mol Neurodegener 14(1):3. https:\/\/doi.org\/10.1186\/s13024-018-0304-2","journal-title":"Mol Neurodegener"},{"issue":"1","key":"12565_CR46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13024-021-00425-8","volume":"16","author":"Y Shao","year":"2021","unstructured":"Shao Y, Li T, Liu Z, Wang X, Xu X, Li S, Xu G, Le W (2021b) Comprehensive metabolic profiling of Parkinson\u2019s disease by liquid chromatography-mass spectrometry. Mol Neurodegener 16(1):4. https:\/\/doi.org\/10.1186\/s13024-021-00425-8","journal-title":"Mol Neurodegener"},{"key":"12565_CR47","doi-asserted-by":"publisher","first-page":"108352","DOI":"10.1016\/j.neuropharm.2020.108352","volume":"190","author":"G Marucci","year":"2021","unstructured":"Marucci G, Amenta F, Volpini R, Lambertucci C, Ben D, Buccioni M (2021) Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease. Neuropharmacology 190:108352. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108352","journal-title":"Neuropharmacology"},{"issue":"20","key":"12565_CR48","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.3390\/ijms21207452","volume":"21","author":"VN Bukke","year":"2020","unstructured":"Bukke VN, Archana M, Villani R, Romano AD, Wawrzyniak A, Balawender K, Orkisz S, Beggiato S, Serviddio G, Cassano T (2020) The dual role of glutamatergic neurotransmission in alzheimer\u2019s disease: from pathophysiology to pharmacotherapy. Int J Mol Sci 21(20):7452. https:\/\/doi.org\/10.3390\/ijms21207452","journal-title":"Int J Mol Sci"},{"issue":"6","key":"12565_CR49","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41380-023-02113-z","volume":"28","author":"N Basheer","year":"2023","unstructured":"Basheer N, Smolek T, Hassan Md I, Liu F, Iqbal K, \u017dilka N, Nov\u00e1k P (2023) Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer\u2019s disease? From preclinical studies to the clinical trials. Mol Psychiatry 28(6):2197\u20132214. https:\/\/doi.org\/10.1038\/s41380-023-02113-z","journal-title":"Mol Psychiatry"},{"key":"12565_CR50","doi-asserted-by":"publisher","first-page":"115218","DOI":"10.1016\/j.biopha.2023.115218","volume":"165","author":"Y Li","year":"2023","unstructured":"Li Y, Xu H, Wang H, Yang K, Luan J, Wang S (2023) TREM2: Potential therapeutic targeting of microglia for Alzheimer\u2019s disease. Biomed Pharmacother 165:115218. https:\/\/doi.org\/10.1016\/j.biopha.2023.115218","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"12565_CR51","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1038\/s41598-023-34355-w","volume":"13","author":"ZH Wei","year":"2023","unstructured":"Wei ZH, Koya J, Acharekar N, Trejos J, Dong XD, Schanne FA, Ashby CR Jr, Reznik SE (2023) N,N-dimethylacetamide targets neuroinflammation in Alzheimer\u2019s disease in-vitro and ex-vivo models. Sci Rep 13(1):7077. https:\/\/doi.org\/10.1038\/s41598-023-34355-w","journal-title":"Sci Rep"},{"issue":"1","key":"12565_CR52","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1146\/annurev-immunol-101921-035222","volume":"42","author":"A Mary","year":"2024","unstructured":"Mary A, Mancuso R, Heneka MT (2024) Immune ctivation in Alzheimer disease. Open repository and bibliography. (University Luxembourg) 42(1):585\u2013613. https:\/\/doi.org\/10.1146\/annurev-immunol-101921-035222","journal-title":"(University Luxembourg)"},{"issue":"1","key":"12565_CR53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4196\/kjpp.2020.24.1.39","volume":"24","author":"JY Ye","year":"2020","unstructured":"Ye JY, Li L, Hao QM, Qin Y, Ma C (2020) \u03b2-Sitosterol treatment attenuates cognitive deficits and prevents amyloid plaque deposition in amyloid protein precursor\/presenilin 1 mice. Korean J Physiol Pharmacol 24(1):39\u201339. https:\/\/doi.org\/10.4196\/kjpp.2020.24.1.39","journal-title":"Korean J Physiol Pharmacol"},{"issue":"1","key":"12565_CR54","doi-asserted-by":"publisher","first-page":"106072","DOI":"10.1016\/j.arabjc.2024.106072","volume":"18","author":"M Sajad","year":"2024","unstructured":"Sajad M, Ali R, Kumar R, Khan NJ, Wahab S, Alshehri SA, Thakur SC (2024) \u03b2-Sitosterol ameliorates the cognitive deficits and neuropathological hallmarks in an Alzheimer\u2019s disease model. Arab J Chem 18(1):106072\u2013106072. https:\/\/doi.org\/10.1016\/j.arabjc.2024.106072","journal-title":"Arab J Chem"},{"key":"12565_CR55","doi-asserted-by":"publisher","DOI":"10.14719\/pst.2420","author":"A Mishra","year":"2023","unstructured":"Mishra A, Das S, Kumari S (2023a) Potential role of herbal plants and beta sitosterol as a bioactive constituent in circumventing Alzheimer\u2019s Disease. Plant Sci Today. https:\/\/doi.org\/10.14719\/pst.2420","journal-title":"Plant Sci Today"},{"key":"12565_CR56","doi-asserted-by":"publisher","unstructured":"Mishra A, Das S, Kumari S, Kanda A, Prabhakar V (2023b) The potential of herbal plants and bioactive \u03b2 sitosterol in circumventing Alzheimer\u2019s disease \u2013 A review. J Nat Remedies 727\u2013745. https:\/\/doi.org\/10.18311\/jnr\/2023\/32973","DOI":"10.18311\/jnr\/2023\/32973"},{"issue":"4","key":"12565_CR57","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.cpan.2025.03.005","volume":"21","author":"M Khedraoui","year":"2025","unstructured":"Khedraoui M, Guerguer FZ, Karim EM, Errougui A, Chtita S (2025) In silico exploration of Aloe vera leaf compounds as dual AChE and BChE inhibitors for Alzheimer\u2019s disease therapy. Curr Pharm Anal 21(4):238\u2013248. https:\/\/doi.org\/10.1016\/j.cpan.2025.03.005","journal-title":"Curr Pharm Anal"},{"key":"12565_CR58","doi-asserted-by":"publisher","unstructured":"Mahnashi MH, Alyami BA, Alqahtani YS, Alqarni AO, Jan MS, Hussain F, Zafar R, Rashid U, Abbas M, Tariq M, Sadiq A (2022) Antioxidant molecules isolated from edible prostrate knotweed: rational derivatization to produce more potent molecules. Oxid Med Cell Longev 3127480. https:\/\/doi.org\/10.1155\/2022\/3127480","DOI":"10.1155\/2022\/3127480"},{"issue":"1","key":"12565_CR59","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1038\/s41598-018-22485-5","volume":"8","author":"R Ahmad","year":"2018","unstructured":"Ahmad R, Sahidin I, Taher M, Low C, Noor NM, Sillapachaiyaporn C, Chuchawankul S, Sarachana T, Tencomnao T, Iskandar F, Rajab NF, Baharum SN (2018) Polygonumins A, a newly isolated compound from the stem of Polygonum minus Huds with potential medicinal activities. Sci Rep 8(1):4202. https:\/\/doi.org\/10.1038\/s41598-018-22485-5","journal-title":"Sci Rep"},{"issue":"1","key":"12565_CR60","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/biomedicines10010154","volume":"10","author":"S Azam","year":"2022","unstructured":"Azam S, Park JY, Kim IS, Choi DK (2022) Piperine and its metabolite\u2019s pharmacology in neurodegenerative and neurological diseases. Biomed 10(1):154. https:\/\/doi.org\/10.3390\/biomedicines10010154","journal-title":"Biomed"},{"key":"12565_CR61","doi-asserted-by":"publisher","first-page":"101089","DOI":"10.1016\/j.redox.2018.10108","volume":"21","author":"W Fischer","year":"2019","unstructured":"Fischer W, Currais A, Liang Z, Pinto A, Maher P (2019) Old age-associated phenotypic screening for Alzheimer\u2019s disease drug candidates identifies sterubin as a potent neuroprotective compound from Yerba santa. Redox Biol 21:101089. https:\/\/doi.org\/10.1016\/j.redox.2018.10108","journal-title":"Redox Biol"},{"key":"12565_CR62","doi-asserted-by":"publisher","first-page":"884345","DOI":"10.3389\/fnins.2022.884345","volume":"16","author":"BA Bhat","year":"2022","unstructured":"Bhat BA, Almilaibary A, Mir RA, Aljarallah B, Mir WR, Ahmad F, Mir MA (2022) Natural therapeutics in aid of treating Alzheimer\u2019s disease: A green gateway toward ending quest for treating neurological disorders. Front Neurosci 16:884345\u2013884345. https:\/\/doi.org\/10.3389\/fnins.2022.884345","journal-title":"Front Neurosci"},{"issue":"5","key":"12565_CR63","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.3390\/molecules28052306","volume":"28","author":"FJ Mirza","year":"2023","unstructured":"Mirza FJ, Zahid S, Holsinger RMD (2023) Neuroprotective effects of carnosic acid: insight into its mechanisms of action. Molecules 28(5):2306\u20132306. https:\/\/doi.org\/10.3390\/molecules28052306","journal-title":"Molecules"},{"issue":"1","key":"12565_CR64","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5530\/ijpi.14.1.15","volume":"14","author":"H Sharma","year":"2023","unstructured":"Sharma H, Chandra P (2023) Challenges and future prospects: A benefaction of phytoconstituents on molecular targets pertaining to Alzheimer\u2019s disease. Intl J Pharm Invest 14(1):117\u2013126. https:\/\/doi.org\/10.5530\/ijpi.14.1.15","journal-title":"Intl J Pharm Invest"},{"issue":"3","key":"12565_CR65","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/antiox14030293","volume":"14","author":"P Banerjee","year":"2025","unstructured":"Banerjee P, Wang Y, Carnevale LN, Patel P, Raspur CK, Tran N, Zhang X, Natarajan R, Roberts AJ, Baran PS, Lipton SA (2025) diAcCA, a pro-drug for carnosic acid that activates the Nrf2 transcriptional pathway, shows efficacy in the 5xFAD transgenic mouse model of Alzheimer\u2019s disease. Antioxidants 14(3):293\u2013293. https:\/\/doi.org\/10.3390\/antiox14030293","journal-title":"Antioxidants"},{"issue":"4","key":"12565_CR66","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41419-022-04765-1","volume":"13","author":"YB Wang","year":"2022","unstructured":"Wang YB, Li X, Bing Y, Zhang Q, Fei-Tong J, Wang M, Zhang X, Le K, Li Y, Sui P, Gao Y, Xu Y, Wang C (2022) Inhibition of the CEBP\u03b2-NF\u03baB interaction by nanocarrier-packaged carnosic acid ameliorates glia-mediated neuroinflammation and improves cognitive function in an Alzheimer\u2019s disease model. Cell Death Dis 13(4):318\u2013318. https:\/\/doi.org\/10.1038\/s41419-022-04765-1","journal-title":"Cell Death Dis"},{"issue":"6","key":"12565_CR67","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s10787-020-00751-1","volume":"28","author":"OA Olajide","year":"2020","unstructured":"Olajide OA, Sarker SD (2020) Alzheimer\u2019s disease: natural products as inhibitors of neuroinflammation. Inflammopharmacology 28(6):1439\u20131455. https:\/\/doi.org\/10.1007\/s10787-020-00751-1","journal-title":"Inflammopharmacology"},{"key":"12565_CR68","doi-asserted-by":"publisher","first-page":"114812","DOI":"10.1016\/j.biopha.2023.114812","volume":"163","author":"J Choi","year":"2023","unstructured":"Choi J, Choi SY, Hong Y, Han YE, Oh SJ, Lee B, Choi CW, Kim MS (2023) The central administration of vitisin A, extracted from Vitis vinifera, improves cognitive function and related signaling pathways in a scopolamine-induced dementia model. Biomed Pharmacother 163:114812. https:\/\/doi.org\/10.1016\/j.biopha.2023.114812","journal-title":"Biomed Pharmacother"},{"key":"12565_CR69","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fnins.2019.00249","volume":"13","author":"I Chalatsa","year":"2019","unstructured":"Chalatsa I, Arvanitis DA, Koulakiotis NS, Giagini A, Skaltsounis AL, Papadopoulou-Daifoti Z, Tsarbopoulos A, Sanoudou D (2019) The Crocus sativus compounds trans-crocin 4 and trans-crocetin modulate the amyloidogenic pathway and tau misprocessing in Alzheimer disease neuronal cell culture models. Front Neurosci 13:249. https:\/\/doi.org\/10.3389\/fnins.2019.00249","journal-title":"Front Neurosci"},{"issue":"1","key":"12565_CR70","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12974-021-02182-3","volume":"18","author":"X Sun","year":"2021","unstructured":"Sun X, Li L, Dong Q, Zhu J, Huang Y, Hou S, Yu X, Liu R (2021) Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer\u2019s disease. J Neuroinflamm 18(1):131\u2013131. https:\/\/doi.org\/10.1186\/s12974-021-02182-3","journal-title":"J Neuroinflamm"},{"issue":"6","key":"12565_CR71","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/plants13060771","volume":"13","author":"V Lerose","year":"2024","unstructured":"Lerose V, Ponticelli M, Benedetto N, Carlucci V, Lela L, Tzvetkov N, Milella L (2024) Withania somnifera (L.) Dunal, a potential source of phytochemicals for treating neurodegenerative diseases: A systematic review. Plants 13(6):771\u2013771. https:\/\/doi.org\/10.3390\/plants13060771","journal-title":"Plants"},{"issue":"11","key":"12565_CR72","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.3390\/ijms26115403","volume":"26","author":"G Tancreda","year":"2025","unstructured":"Tancreda G, Ravera S, Panfoli I (2025) Preclinical evidence of Withania somnifera and Cordyceps spp.: Neuroprotective properties for the management of Alzheimer\u2019s disease. Int J Mol Sci 26(11):5403\u20135403. https:\/\/doi.org\/10.3390\/ijms26115403","journal-title":"Int J Mol Sci"},{"issue":"6","key":"12565_CR73","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3390\/ph18060816","volume":"18","author":"L Yang","year":"2025","unstructured":"Yang L, Zou Y, Fan J, Yin P, Qin H, Li Z, Wu F, Li X, Teng HB, Zhang Y, Chen X, Li SC (2025) Withaferin A rescues brain network dysfunction and cognitive deficits in a mouse model of Alzheimer\u2019s disease. Pharmaceuticals 18(6):816\u2013816. https:\/\/doi.org\/10.3390\/ph18060816","journal-title":"Pharmaceuticals"},{"issue":"2","key":"12565_CR74","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/brainsci14020130","volume":"14","author":"ASP Savall","year":"2024","unstructured":"Savall ASP, Mello JD, de Fid\u00e9lis EM, Comis-Neto AA, Nepomuceno MR, Pacheco C, de Haas O, Pinton SE S (2024) Nanoencapsulated curcumin: Enhanced efficacy in reversing memory loss in an Alzheimer disease model. Brain Sci 14(2):130\u2013130. https:\/\/doi.org\/10.3390\/brainsci14020130","journal-title":"Brain Sci"},{"key":"12565_CR75","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-6363905\/v2","author":"D\u00d6 S\u00f6ylemez","year":"2025","unstructured":"S\u00f6ylemez D\u00d6, Unur E, Sa\u011f\u0131r D (2025) Protective effects of curcumin and resveratrol onneurodegeneration and cognitive dysfunction in a streptozotocin-induced Alzheimer rat model. Res Square. https:\/\/doi.org\/10.21203\/rs.3.rs-6363905\/v2","journal-title":"Res Square"},{"issue":"1","key":"12565_CR76","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3233\/JAD-180251","volume":"64","author":"Y Du","year":"2018","unstructured":"Du Y, Fu M, Wang YT, Dong Z, Zhu L-Q (2018) Neuroprotective effects of ginsenoside rf on amyloid-\u03b2-induced neurotoxicity in vitro and in vivo. J Alzheimer\u2019s Dis 64(1):309\u2013322. https:\/\/doi.org\/10.3233\/JAD-180251","journal-title":"J Alzheimer\u2019s Dis"},{"key":"12565_CR77","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/978-3-030-21048-9_18","volume-title":"Fate and Effects of Anticancer Drugs in the Environment","author":"G Mastroianni","year":"2020","unstructured":"Mastroianni G, Scognamiglio M, Russo C, Fiorentino A, Lavorgna M (2020) Environmental metabolomics: A powerful tool to investigate biochemical responses to drugs in nontarget organisms. In: Lavorgna M, Russo C (eds) Fate and Effects of Anticancer Drugs in the Environment. Springer, Cham, pp 441\u2013465"},{"key":"12565_CR78","doi-asserted-by":"publisher","first-page":"101089","DOI":"10.1016\/j.redox.2018.101089","volume":"21","author":"W Fischer","year":"2019","unstructured":"Fischer W, Currais A, Liang Z, Pinto A, Maher P (2019) Old age-associated phenotypic screening for Alzheimer\u2019s disease drug candidates identifies sterubin as a potent neuroprotective compound from Yerba santa. Redox Biol 21:101089. https:\/\/doi.org\/10.1016\/j.redox.2018.101089","journal-title":"Redox Biol"},{"key":"12565_CR79","doi-asserted-by":"publisher","first-page":"7040","DOI":"10.1038\/s41598-019-43537-4","volume":"9","author":"G Li","year":"2019","unstructured":"Li G, Zhang N, Geng F, Liu G, Liu B, Lei X, Li G, Chen X (2019) High-throughput metabolomics and ingenuity pathway approach reveals the pharmacological effect and targets of Ginsenoside Rg1 in Alzheimer\u2019s disease mice. Sci Rep 9:7040. https:\/\/doi.org\/10.1038\/s41598-019-43537-4","journal-title":"Sci Rep"},{"key":"12565_CR80","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3389\/fphar.2017.00697","volume":"8","author":"M Ayaz","year":"2017","unstructured":"Ayaz M, Junaid M, Ullah F, Subhan F, Sadiq A, Ali G, Ovais M, Shahid M, Ahmad A, Wadood A, El-Shazly M, Ahmad N, Ahmad S (2017) Anti-Alzheimer\u2019s studies on \u03b2-sitosterol isolated from Polygonum hydropiper L. Front Pharmacol 8:697. https:\/\/doi.org\/10.3389\/fphar.2017.00697","journal-title":"Front Pharmacol"},{"issue":"24","key":"12565_CR81","doi-asserted-by":"publisher","first-page":"7626","DOI":"10.3390\/molecules26247626","volume":"26","author":"LH Nurani","year":"2021","unstructured":"Nurani LH, Rohman A, Windarsih A, Guntarti A, Riswanto FDO, Lukitaningsih E, Fadzillah NA, Rafi M (2021) Metabolite fingerprinting using 1H-NMR spectroscopy and chemometrics for classification of three curcuma species from different origins. Molecules 26(24):7626. https:\/\/doi.org\/10.3390\/molecules26247626","journal-title":"Molecules"},{"key":"12565_CR82","doi-asserted-by":"publisher","first-page":"27045","DOI":"10.1038\/s41598-025-12937-0","volume":"15","author":"J Chen","year":"2025","unstructured":"Chen J, Wei C, Zhang Y, Chen Q, Li X, Zhang W, Zhang Z, Han F (2025) Curcumin exerts neuroprotective effects on proliferation of neural stem cells in vitro and APP\/PS1 mouse model in vivo. Sci Rep 15:27045. https:\/\/doi.org\/10.1038\/s41598-025-12937-0","journal-title":"Sci Rep"},{"key":"12565_CR83","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cyto.2017.10.019","volume":"102","author":"A Pandey","year":"2018","unstructured":"Pandey A, Qazi G, Suri K, Satti N, Dutt P, Bani S (2018) Multifunctional neuroprotective effect of Withanone, a compound from Withania somnifera roots in alleviating cognitive dysfunction. Cytokine 102:211\u2013221. https:\/\/doi.org\/10.1016\/j.cyto.2017.10.019","journal-title":"Cytokine"},{"issue":"1","key":"12565_CR84","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/biomedicines10010154","volume":"10","author":"S Azam","year":"2022","unstructured":"Azam S, Park JY, Kim IS, Choi DK (2022) Piperine and its metabolite\u2019s pharmacology in neurodegenerative and neurological diseases. Biomed 10(1):154. https:\/\/doi.org\/10.3390\/biomedicines10010154","journal-title":"Biomed"},{"issue":"1","key":"12565_CR85","doi-asserted-by":"publisher","first-page":"100184","DOI":"10.1016\/j.phyplu.2021.100184","volume":"2","author":"R Taqui","year":"2022","unstructured":"Taqui R, Debnath M, Ahmed S, Ghosh A (2022) Advances on plant extracts and phytocompounds with acetylcholinesterase inhibition activity for possible treatment of Alzheimer\u2019s disease. Phytomed Plus 2(1):100184. https:\/\/doi.org\/10.1016\/j.phyplu.2021.100184","journal-title":"Phytomed Plus"},{"issue":"8","key":"12565_CR86","doi-asserted-by":"publisher","first-page":"e104621","DOI":"10.1371\/journal.pone.0104621","volume":"9","author":"KL Chang","year":"2014","unstructured":"Chang KL, Ho PC (2014) Gas chromatography time-of-flight mass spectrometry (GC-TOF-MS)-based metabolomics for comparison of caffeinated and decaffeinated coffee and its implications for Alzheimer\u2019s disease. PLoS ONE 9(8):e104621. https:\/\/doi.org\/10.1371\/journal.pone.0104621","journal-title":"PLoS ONE"},{"key":"12565_CR87","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/jfbc.12263","volume":"40","author":"J Acharya","year":"2016","unstructured":"Acharya J, Karak S, De B (2016) Metabolite profile and bioactivity of Musa X Paradisiaca L. flower extracts. J Food Biochem 40:724\u2013730. https:\/\/doi.org\/10.1111\/jfbc.12263","journal-title":"J Food Biochem"},{"key":"12565_CR88","doi-asserted-by":"publisher","first-page":"108352","DOI":"10.1016\/j.neuropharm.2020.108352","volume":"190","author":"G Marucci","year":"2020","unstructured":"Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F (2020) Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease. Neuropharmacology 190:108352\u2013108352. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108352","journal-title":"Neuropharmacology"},{"key":"12565_CR89","doi-asserted-by":"publisher","first-page":"19220","DOI":"10.3390\/molecules191119220","volume":"19","author":"R Ahmad","year":"2014","unstructured":"Ahmad R, Baharum SN, Bunawan H, Lee MK, Noor NM, Rohani ER, Ilias N, Zin NM (2014) Volatile profiling of aromatic traditional medicinal plant, Polygonum minus in different tissues and its biological activities. Molecules 19:19220\u201319242. https:\/\/doi.org\/10.3390\/molecules191119220","journal-title":"Molecules"},{"issue":"12","key":"12565_CR90","doi-asserted-by":"publisher","first-page":"84","DOI":"10.22270\/jddt.v13i12.6322","volume":"13","author":"BDA Ambamba","year":"2023","unstructured":"Ambamba BDA, Pieben CQN, Kenassi MBN, Ebouel FLE, Nanhah JVK, Ella FA, Ngoumen DJN, Talla RM, Mandob DE, Ngondi JL (2023) In silico pharmacological study of lacourtianal, a new terpenoid isolated from the stem bark of Chrysophyllum lacourtianum De Wild (Sapotaceae) against Alzheimer\u2019s disease. J Drug Deliv Ther 13(12):84\u201390. https:\/\/doi.org\/10.22270\/jddt.v13i12.6322","journal-title":"J Drug Deliv Ther"},{"issue":"9","key":"12565_CR91","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.3390\/app14093898","volume":"14","author":"E Lima","year":"2024","unstructured":"Lima E, Medeiros J (2024) Terpenes as potential anti-Alzheimer\u2019s disease agents. Appl Sci 14(9):3898\u20133898. https:\/\/doi.org\/10.3390\/app14093898","journal-title":"Appl Sci"},{"issue":"1","key":"12565_CR92","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1080\/13880209.2020.1758732","volume":"58","author":"X Deng","year":"2020","unstructured":"Deng X, Zhao S, Liu X, Han L, Wang R, Hao H, Jiao Y, Han S, Bai C (2020) Polygala tenuifolia: a source for anti-Alzheimer\u2019s disease drugs. Pharma Biol 58(1):410\u2013416. https:\/\/doi.org\/10.1080\/13880209.2020.1758732","journal-title":"Pharma Biol"},{"key":"12565_CR93","doi-asserted-by":"publisher","first-page":"688703","DOI":"10.3389\/fpsyt.2021.688703","volume":"12","author":"N Jiang","year":"2021","unstructured":"Jiang N, Wei S, Zhang Y, He W, Pei H, Huang H, Wang Q, Liu X (2021) Protective effects and mechanism of Radix polygalae against neurological diseases as well as effective substance. Front Psychiatry 12:688703\u2013688703. https:\/\/doi.org\/10.3389\/fpsyt.2021.688703","journal-title":"Front Psychiatry"},{"issue":"2","key":"12565_CR94","doi-asserted-by":"publisher","first-page":"86","DOI":"10.63240\/jmm-nimm.2025.2.108","volume":"30","author":"LB Vinh","year":"2025","unstructured":"Vinh LB, Ch\u00ednh NV, Cuong NC (2025) Triterpenoid saponins from the roots of Polygala tenuifolia: in vitro and in silico study of acetylcholinesterase inhibitory activities. T\u1ea1p Ch\u00ed D\u01b0\u1ee3c Li\u1ec7u 30(2):86\u201391. https:\/\/doi.org\/10.63240\/jmm-nimm.2025.2.108","journal-title":"T\u1ea1p Ch\u00ed D\u01b0\u1ee3c Li\u1ec7u"},{"issue":"2","key":"12565_CR95","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1042\/ETLS20210262","volume":"6","author":"S Gupta","year":"2022","unstructured":"Gupta S, Schillaci M, Roessner U (2022) Metabolomics as an emerging tool to study plant\u2013microbe interactions. Emerg Top Life Sci 6(2):175\u2013183. https:\/\/doi.org\/10.1042\/ETLS20210262","journal-title":"Emerg Top Life Sci"},{"issue":"5","key":"12565_CR96","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11306-022-01878-8","volume":"18","author":"CT Yu","year":"2022","unstructured":"Yu CT, Chao BN, Barajas R, Haznadar M, Maruvada P, Nicastro H, Zanetti KA (2022) An evaluation of the National Institutes of Health grants portfolio: identifying opportunities and challenges for multi-omics research that leverage metabolomics data. Metabolomics 18(5):29. https:\/\/doi.org\/10.1007\/s11306-022-01878-8","journal-title":"Metabolomics"},{"issue":"1","key":"12565_CR97","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/med.21847","volume":"42","author":"Y Pan","year":"2022","unstructured":"Pan Y, Lei X, Zhang Y (2022) Association predictions of genomics, proteinomics, transcriptomics, microbiome, metabolomics, pathomics, radiomics, drug, symptoms, environment factor, and disease networks: A comprehensive approach. Med Res Rev 42(1):441\u2013461. https:\/\/doi.org\/10.1002\/med.21847","journal-title":"Med Res Rev"},{"issue":"2","key":"12565_CR98","first-page":"83","volume":"10","author":"AA Oskouie","year":"2018","unstructured":"Oskouie AA, Yekta RF, Tavirani MR, Kashani MS, Goshadrou F (2018) Lavandula angustifolia effects on rat models of Alzheimer\u2019s disease through the investigation of serum metabolic features using NMR metabolomics. Avicenna J Med Biotechnol 10(2):83\u201392","journal-title":"Avicenna J Med Biotechnol"},{"key":"12565_CR99","doi-asserted-by":"publisher","first-page":"105143","DOI":"10.1016\/j.neuint.2021.105143","volume":"149","author":"KL Ooi","year":"2021","unstructured":"Ooi KL, Vacy M, Boon WC (2021) Fatty acids and beyond: Age and Alzheimer\u2019s disease related changes in lipids reveal the neuro-nutraceutical potential of lipids in cognition. Neurochem Int 149:105143. https:\/\/doi.org\/10.1016\/j.neuint.2021.105143","journal-title":"Neurochem Int"},{"issue":"5","key":"12565_CR100","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/antiox7050063","volume":"7","author":"A Pinto","year":"2018","unstructured":"Pinto A, Bonucci A, Maggi E, Corsi M, Businaro R (2018) Antioxidant and anti-inflammatory activity of ketogenic diet: New perspectives for neuroprotection in Alzheimer\u2019s disease. Antioxid (Basel Switzerland) 7(5):63. https:\/\/doi.org\/10.3390\/antiox7050063","journal-title":"Antioxid (Basel Switzerland)"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12565-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12565-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12565-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:46:44Z","timestamp":1786697204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12565-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12565"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12565-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1403"}}